Appendix 4E Preliminary Final Report FY25
Open PDF
| Stock | Adheris Health Limited (AHE.ASX) |
|---|---|
| Release Time | 29 Aug 2025, 9:47 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
MedAdvisor Reports FY25 Preliminary Results
Key Points
- Revenue down 36% to $62.9 million
- Loss of $60.2 million, a 7700.9% decrease from prior year
- Impairment of $46.5 million in assets
Full Summary
MedAdvisor Limited has reported its preliminary financial results for the year ended 30 June 2025. The company's revenue declined 36% to $62.9 million, while it recorded a loss of $60.2 million, a 7700.9% decrease from the prior year's profit of $792,133. The loss was driven by a $46.5 million impairment of assets, primarily related to the company's US operations which faced significant challenges due to industry and regulatory changes. The company also reported a decline in net tangible assets per ordinary security from (2.40) cents to (0.26) cents. MedAdvisor did not pay, recommend or declare any dividends during the current or previous financial year.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In